Board of Directors

François Ravenelle, PhD

Founder & CEO


Dr. Ravenelle is championing the comeback of cannabinoid receptor-1 (CB1) blockers at Inversago Pharma Inc.

An entrepreneur with 16 years of industrial R&D experience,  his background includes pharmaceutical development from discovery through NDA approval.

Jamie Stiff, BSc, MBA

Managing Director, Genesys Capital


Mr. Stiff is Managing Director at Genesys Capital, a life science focused venture firm.

Over his career, he has been responsible for investments in several early stage portfolio companies that cross a multitude of clinical disciplines and technology areas.

Maxime Ranger, PhD, MBA

General Partner, AmorChem


Dr. Ranger is a General Partner at AmorChem, an early-stage venture capital fund specialized in life science.

As a serial entrepreneur in the biotech industry, his expertise includes drug development across a range of therapeutic indications including oncology, hepatology, gastroenterology and metabolic conditions, such as NASH, Prader-Willi Syndrome, type-2 diabetes and obesity.

Dr. Ranger is a co-author of 30+ scientific publications in international peer-reviewed journals.